
Loading...
The Bureau of Indian Standards (BIS) is responsible for ensuring that all toys manufactured in India meet Indian standards. know the Process of BIS Certifications & Legal Compliance For Import Toys Into India.

About the Author
_copy.jpg&w=1536&q=75)
I'm Aastha, a fresh graduate and I worked with many news agencies and startup. I'm passionate about writing blogs and news stories. Now, I'm working as a content writer at Corpseed ITES Private Limited.
Related articles

BIS IS 302-2-80: Household and Similar Electrical Appliances – Safety Part 2-80: Particular Requirements for Fans
2026-04-22

Download Appointment Letter Format in Word and PDF
2022-02-17 • 135390 views
Latest Articles
Recently published

Why Businesses Need CDSCO Consultants in India
2026-06-12 • 587 views

How to Secure New Drug Clinical Trial Approval in India?
2026-06-12 • 568 views

Common Reasons CDSCO Applications Get Delayed or Rejected
2026-06-12 • 857 views

CDSCO Approval for Cosmetic Products in India
2026-06-11 • 1101 views

Schedule M Compliance for Manufacturers Seeking CDSCO-related Licenses
2026-06-10 • 1824 views
Top News
Trending

Salary Slip Format In Excel, Word, PDF, PaySlip Format Online
2023-02-27
.png&w=1536&q=75)
Increment Letter Format - Salary Increment Letter With Salary Break Up Format In Word and PDF
2023-02-27

Latest Marriage Biodata Formats | Biodata Format for Marriage Download in Word and PDF
2023-02-27

New Form 15G in Word Format | Download Form 15G in Word and PDF Format
2023-02-27
.png&w=1536&q=75)
Job Offer Letter Format With Word And PDF Templates Download
2022-07-19
Latest News
Fresh updates

BIS Notifies New Indian Standards Across Key Sectors to Strengthen Quality and Safety
2026-06-12

BIS New Standards for Lithium Batteries, EV Cells, and Service Excellence impact on Indian Businesses in 2026
2026-06-12

EU Retains India on Approved List for Aquaculture and Animal Product Exports
2026-06-10

Aadhaar Authentication Mandatory for MNRE Research Scheme Benefits
2026-06-09

CDSCO Directs Stakeholders to Maintain Pharmacovigilance System under Schedule M
2026-06-08